Showing results (631-640 of 2,753) with videos related to

Sort By:
Pageof 276
Neoplasia (New York, N.Y.)|November 22, 2025
Exposure to diesel particulates induces an immunosuppressive microenvironment that promotes the progression of lung cancerMarie-Laure Delhez, Maëlle Bosmans, Lucia Rodriguez Rodriguez, et al.
Neoplasia (New York, N.Y.)|November 29, 2025
Filamin a binds deleted in liver cancer 1 (DLC1) to promote its tumor suppressor activity and inhibit the SRF coactivator MRTF-AMichael Sergeev, Melanie A Meier, Petra Wohlleben, et al.
Neoplasia (New York, N.Y.)|November 26, 2025
OTUD4-ZMYND8-DDX3X Axis Drives Immunosuppressive Microenvironment in Spinal Metastases of Triple-Negative Breast CancerBing Liang, Annan Hu, Hongwei Lu, et al.
Neoplasia (New York, N.Y.)|May 11, 2024
Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS productionRunde Wang, Liuyi Zhong, Tiepeng Wang, et al.
Neoplasia (New York, N.Y.)|January 10, 2024
Genetically engineered mouse model of pleomorphic liposarcoma: Immunophenotyping and histologic characterizationJeffrey Mark Brown, Rahi Patel, Kyllie Smith-Fry, et al.
Neoplasia (New York, N.Y.)|December 22, 2023
Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancersAyat Lashen, Abdulbaqi Al-Kawaz, Jennie N Jeyapalan, et al.
Neoplasia (New York, N.Y.)|January 17, 2024
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trialMarkus Hecht, Benjamin Frey, Udo S Gaipl, et al.
Neoplasia (New York, N.Y.)|January 14, 2024
RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cellsFengxu Lv, Wentao Si, Xiaodan Xu, et al.
Neoplasia (New York, N.Y.)|June 17, 2026
Inaccurate interpretation of hypoxia signatures from transcriptomic analyses in neuro-oncologyRebecca K Simmons, Pratima Raut, Subhi Talal Younes, et al.
Neoplasia (New York, N.Y.)|June 16, 2026
Hypoxia-activated PROTAC for dual inhibition of FAK and EGFR enables synergistic mechano-chemical cancer therapyKeli An, Yuan Li, Chunyu Cao, et al.
Pageof 276